• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Shire CEO Ornskov racks up $21M in pay, a fivefold leap from 2014

    FIERCE PHARMA

    With Baxalta in hand, Shire`s not looking to buy. But sell? Maybe

    FIERCE PHARMA

    Pharma M&A shoots up to $159B for first half, but prices could dampen the mood

    FIERCE PHARMA

    What’s Real in Rare Disease

    PHARM EXEC.COM

    Careful, European drugmakers. Fitch says M&A may be a bit too heated

    FIERCE PHARMA

    EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX)

    BIOSPACE

    RARE Alert: Shire Said To Be Weighing

    BETAVILLE

    Shire`s Shopping Spree Continues With A $245M Deal To Buy PhIII-Ready Meritage

    FIERCE BIOTECH

    Pharma`s Top 10 M&A Deals of 2014

    FIERCE PHARMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.